SSc Autoantibody Identified with Link to GI Dysfunction

If validated as a biomarker, anti-gephyrin autoantibodies could help identify patients at higher risk for GI symptoms like constipation.
Medscape Medical News

source https://www.medscape.com/viewarticle/995259?src=rss